Share
PDF
Other content recommended for you
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Why NIPT should be publicly funded
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Hostile environments? Down’s syndrome and genetic screening in contemporary culture
- ‘Is it better not to know certain things?’: views of women who have undergone non-invasive prenatal testing on its possible future applications
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis
- Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection